|
|
|
Our Current Projects:
Currently we are associated with Multi National Company for its project (Phase III) in the field of Nephrology, Gynaecology and with another MNC for its post market surveillance in oncology specialty.
This shows clinical research/pharma industry's faith upon us for precise and reliable data.
Ongoing Trials:
1. Study to evaluate the efficacty of Erlotinib (TarcevaŽ ) following 4 cycles of platinum based chemotherapy in patients with locally advanced or metastatic non small cell lung cancer (NSCLC) who have not experienced disease progression or unacceptable toxicity during Chemotherapy
2. A Study to assess the safety and efficacy of Cetuximab plus Radiotherapy (RT) in Locally Advanced Squamous Cell Carcinoma of Head & Neck (LA SCCHN)
3. Protocol No. 2-55-52030-730/TR321: Title" A double-blind, randomized placebo- Controlled clinical trial investigating the efficacy and safety of Somatuline Depot (lanreotide) Injection in the treatment of carcinoid syndrome"
4. Protocol WSA-CS-008: A Phase III, Double Blind, Randomized Study to Evaluate the Safety and Efficacy of BAL8557 versus a Caspofungin followed by Voriconazole Regimen in the Treatment of Candidemia and other Invasive Candida Infection"
5. Protocol BI1200.98: An open label, phase II trial of BIBW 2992 (Afatinib) in patients with metastatic HER-2 Over expressing breast cancer failing HER2-targeted treatment in the neoadjuvant or adjuvant treatment setting.
6. A Multi centre, open label, single arm, Phase IV, interventional study to
evaluate the efficacty of Erlotinib (TarcevaŽ )following 4 cycles of
platinum based chemotherapy in patients with locally advanced or metastatic
non small cell lung cancer (NSCLC) who have not experienced disease
progression or unacceptable toxicity during Chemotherapy.
7. A Post-Marketing Surveillance Study to assess the safety and efficacy of
Cetuximab plus Radiotherapy (RT) in Locally Advanced Squamous Cell
Carcinoma of Head & Neck (LA SCCHN).
8. Protocol No. 2-55-52030-730/TR321: Title" A double-blind, randomized
placebo- Controlled clinical trial investigating the efficacy and safety of
Somatuline Depot (lanreotide) Injection in the treatment of carcinoid
syndrome .
9. Protocol WSA-CS-008: A Phase III, Double Blind, Randomized Study to
Evaluate the Safety and Efficacy of BAL8557 versus a Caspofungin followed
by Voriconazole Regimen in the Treatment of Candidemia and other Invasive
Candida Infection.
10. PRESTIGE STUDY : An Open Label, Randomised, Parallel Group, Multicentre Study to Compare ZOLADEX 10.8 mg Given Every 12 Weeks with ZOLADEX 3.6 mg Given Every 4 Weeks in Pre-menopausal Women with Oestrogen Receptor Positive Advanced Breast Cancer.
11. A Open-Label Single-Arm observational Study of Pemetrexed in Combination with Cisplatin in Patients with Advanced stage IIB/IV Non-Small Cell Lung Cancer Cancer to assess the PFS. (Progression Free Survival) in Indian context.
12. An Observational Study to evaluate the safety and efficacy of Erbitux in combination with platinumum based chemotherapy, in the first - line therapy of Recurrent / Metastatic Squamous Cell Carcinoma of Head & Neck (SCCHN)
13. SERENITY STUDY : Study No. - P1446A: An open lable, Multicentre Phase II study of Selective Cyclin Dependent Kinase Inhibitor. In subjects with Advanced Refractory Malignancies.
14. Study No. - BIBF-1193.13 : A multicentre, randomized, double blind, Phase 3 Trial to investigate the efficacy and safety of oral BIBF 1120 plus standard docetaxel therapy compared to placebo plus standard docetaxel therapy in patients with stage IIIB/IV orrecurrent non small cell lung cancer after failure of first line chemotherapy.
15. Bafetinib-P2-HRPC-01-A Phase II Study of Bafetinib (INNO-406) as Treatment for Patient with Hormone- Refractory Prostate Cancer.
16. Fighting cervical cancer, FOGSI cervical cancer registry, a reaching the unreached FOGSI initiative 2010. . A pap smear & HIV DNA & colposcopy based study.
|
|
|
|